Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Carissa Chu(Icahn School of Medicine at Mount Sinai), Jonathan Chou(UCSF Helen Diller Family Comprehensive Cancer Center)
Cited by 154
Related Papers
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
|Cancer Research|2022|58
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
|Oncogene|2017|50
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
|Cell Reports Medicine|2024|28
Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer
|Journal of Nuclear Medicine|2024|26